Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Gillette: Signs of healing - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Apr 2, 2002

    Gillette: Signs of healing

    On the surface Gillette India had a bad 2001. The company finished its financial year with Rs 278 m as net loss. The company also reported a 4% dip in turnover YoY. However, 2001 may well be the base on which Gillette India will launch its expected recovery in 2002.

    (Rs m) 4QFY01 4QFY02 Change FY01 FY02 Change
    Net Sales 3,087 1,524 -50.6% 5,168 4,951 -4.2%
    Other Income 93 64 -30.7% 197 166 -15.8%
    Expenditure 2,868 1,281 -55.3% 4,694 4,492 -4.3%
    Operating Profit (EBDIT) 219 243 11.1% 474 459 -3.3%
    Operating Profit Margin (%) 7.1% 15.9%   9.2% 9.3%  
    Interest 123 46 -62.5% 172 138 -19.8%
    Depreciation 161 82 -49.4% 246 300 22.1%
    Profit before Tax 28 180 550.7% 254 187 -26.4%
    Tax -61 -125   21 -142  
    Extraordinary expenses 31 -636   31 -606  
    Profit after Tax/(Loss) 120 -332   264 -278  
    Net profit margin (%) 3.9% -21.7%   5.1% -5.6%  
    No. of Shares (eoy) (m) 12.9 32.6   12.9 32.6  
    Diluted Earnings per share* 14.7 -40.7   8.1 -8.5  

    True that FY02 has not been a great year for Gillette India. But this has got a lot to do with its Duracell business and its plants than with anything else. The company's Mach 3 brand is reportedly growing at over 35% per annum and the newly bought Wilkinson brand grew by 10% during the year. However, Duracell registered a 4% decline. The Geep line of products is growing at over 9%.

    Gillette has been under pressure ever since it acquired Duracell and Wilkinson in 2000. Though this move added to the company's topline, higher interest and depreciation burden hit the company's profitability. However, the company has taken steps to restructure this anomaly.

    Cost break-up
    (Rs m) FY01 FY02 Change
    Raw material 2,463 2,223 -9.7%
    Staff 294 360 22.5%
    Advertising & selling 523 317 -39.3%
    Others 1,414 1,592 12.6%
    Total expenditure 4,694 4,492 -4.3%

    The company decided to sell Duracell India plant to Duracell Belgium for a consideration of US$ 6.5 m. It closed the Duracell plant at Manesar and consequently took a hit of Rs 606 m for its closure. This component is largely the reason for Gillette India ending FY02 in red. The 50% decline in 4QFY02 is also brought about by the Duracell closure. A major positive for the company is the capital grant of Rs 850 m (US$ 17.5 m) from its parent. The monies realised will be used to retire debts and strive to make Gillette a zero debt company. Also in the coming year, its depreciation will be lower due to the discontinuation of the Duracell plant.

    It is no wonder that the stock has run up by almost 40% in the last three months to Rs 375 levels currently. The year 2002 is expected to be a much better year for Gillette India with low interest and depreciation outgo. However, we believe that the stock is valued at these levels in the medium term.

    Going by the shrinkage of turnover in 4QFY02 (due to Duracell closure), it is likely that Gillette's turnover in FY03 will be significantly lower than FY02. However, even if we assume a flat turnover growth with an improvement in operating margins to 12%, and assume a depreciation of Rs 240 m and an iterest outgo at Rs 50 m, the stock still trades at a relatively high 28x FY03 estimated earnings with the current number of shares outstanding. But Gillette India seems a good investment in the long term owing to the company's management focus, renowned brands and the parent's resolve to concentrate on the Indian shaving products market.



    Equitymaster requests your view! Post a comment on "Gillette: Signs of healing". Click here!


    More Views on News

    Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

    Aug 9, 2017

    While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

    Aug 4, 2017

    The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    Aug 16, 2017 (Close)


    • Track your investment in GILLETTE INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks



    Compare Company With Charts